Monocytes: Protagonists of Infarct Inflammation and Repair After Myocardial Infarction

Overview

Journal Circulation

Specialty Cardiology & Vascular Diseases

Date 2010 Jun 10

PMID 20530020

Citations 397

Authors

Matthias Nahrendorf

Mikael J Pittet

Filip K Swirski

Affiliations

Soon will be listed here.

Citing Articles

Enhancing cardiac repair post-myocardial infarction: a study on GATM/Gel hydrogel therapeutics.

Li T, Ding L, Wang Q, Ma J, Wang S Cell Biol Toxicol. 2025; 41(1):44.

PMID: 39937362 PMC: 11821695. DOI: 10.1007/s10565-025-09987-5.

The future of cardiac repair: a review on cell-free nanotherapies for regenerative myocardial infarction.

Kamal N, A Heikal L, Abdallah O Drug Deliv Transl Res. 2025; .

PMID: 39833466 DOI: 10.1007/s13346-024-01763-y.

Cardiovascular Disease and Cancer: A Dangerous Liaison.

Newman A, Dalman J, Moore K Arterioscler Thromb Vasc Biol. 2025; 45(3):359-371.

PMID: 39781742 PMC: 11864891. DOI: 10.1161/ATVBAHA.124.319863.

Formoterol Reduces the Pro-Inflammatory Phenotype by Enhancing the Activity of Glutaminase in Monocyte-Derived Macrophages in the CVB3-Induced Viral Myocarditis.

Li Q, Xie H, Guo Y, Li J, Qian J, Wu W Immun Inflamm Dis. 2024; 12(11):e70073.

PMID: 39601476 PMC: 11600452. DOI: 10.1002/iid3.70073.

Leukocyte-lymphatic intersections during cardiac inflammation.

Glinton K, Thakkar A, Jones R, Inui H, Ge Z, Thorp E J Mol Cell Cardiol. 2024; 198():13-20.

PMID: 39592090 PMC: 11717605. DOI: 10.1016/j.yjmcc.2024.11.006.

References

Maekawa Y, Anzai T, Yoshikawa T, Sugano Y, Mahara K, Kohno T . Effect of granulocyte-macrophage colony-stimulating factor inducer on left ventricular remodeling after acute myocardial infarction. J Am Coll Cardiol. 2004; 44(7):1510-20. DOI: 10.1016/j.jacc.2004.05.083. View

Ross R . Atherosclerosis--an inflammatory disease. N Engl J Med. 1999; 340(2):115-26. DOI: 10.1056/NEJM199901143400207. View

van Amerongen M, Harmsen M, van Rooijen N, Petersen A, van Luyn M . Macrophage depletion impairs wound healing and increases left ventricular remodeling after myocardial injury in mice. Am J Pathol. 2007; 170(3):818-29. PMC: 1864893. DOI: 10.2353/ajpath.2007.060547. View

Mebius R, Kraal G . Structure and function of the spleen. Nat Rev Immunol. 2005; 5(8):606-16. DOI: 10.1038/nri1669. View

Schwartz S, Galis Z, Rosenfeld M, Falk E . Plaque rupture in humans and mice. Arterioscler Thromb Vasc Biol. 2007; 27(4):705-13. DOI: 10.1161/01.ATV.0000261709.34878.20. View

Lesnik P, Haskell C, Charo I . Decreased atherosclerosis in CX3CR1-/- mice reveals a role for fractalkine in atherogenesis. J Clin Invest. 2003; 111(3):333-40. PMC: 151849. DOI: 10.1172/JCI15555. View

Gu L, Okada Y, Clinton S, Gerard C, Sukhova G, Libby P . Absence of monocyte chemoattractant protein-1 reduces atherosclerosis in low density lipoprotein receptor-deficient mice. Mol Cell. 1998; 2(2):275-81. DOI: 10.1016/s1097-2765(00)80139-2. View

Sutton M, Sharpe N . Left ventricular remodeling after myocardial infarction: pathophysiology and therapy. Circulation. 2000; 101(25):2981-8. DOI: 10.1161/01.cir.101.25.2981. View

Serbina N, Pamer E . Monocyte emigration from bone marrow during bacterial infection requires signals mediated by chemokine receptor CCR2. Nat Immunol. 2006; 7(3):311-7. DOI: 10.1038/ni1309. View

10.

Frangogiannis N, Entman M . Targeting the chemokines in myocardial inflammation. Circulation. 2004; 110(11):1341-2. DOI: 10.1161/01.CIR.0000141560.18364.63. View

11.

Steffens S, Montecucco F, Mach F . The inflammatory response as a target to reduce myocardial ischaemia and reperfusion injury. Thromb Haemost. 2009; 102(2):240-7. DOI: 10.1160/TH08-12-0837. View

12.

Mariani M, Fetiveau R, Rossetti E, Poli A, Poletti F, Vandoni P . Significance of total and differential leucocyte count in patients with acute myocardial infarction treated with primary coronary angioplasty. Eur Heart J. 2006; 27(21):2511-5. DOI: 10.1093/eurheartj/ehl191. View

13.

Cleutjens J, Blankesteijn W, Daemen M, Smits J . The infarcted myocardium: simply dead tissue, or a lively target for therapeutic interventions. Cardiovasc Res. 2000; 44(2):232-41. DOI: 10.1016/s0008-6363(99)00212-6. View

14.

Swirski F, Pittet M, Kircher M, Aikawa E, Jaffer F, Libby P . Monocyte accumulation in mouse atherogenesis is progressive and proportional to extent of disease. Proc Natl Acad Sci U S A. 2006; 103(27):10340-10345. PMC: 1502459. DOI: 10.1073/pnas.0604260103. View

15.

ROBINETTE C, Fraumeni Jr J . Splenectomy and subsequent mortality in veterans of the 1939-45 war. Lancet. 1977; 2(8029):127-9. DOI: 10.1016/s0140-6736(77)90132-5. View

16.

Mildner A, Schmidt H, Nitsche M, Merkler D, Hanisch U, Mack M . Microglia in the adult brain arise from Ly-6ChiCCR2+ monocytes only under defined host conditions. Nat Neurosci. 2007; 10(12):1544-53. DOI: 10.1038/nn2015. View

17.

Weber C, Zernecke A, Libby P . The multifaceted contributions of leukocyte subsets to atherosclerosis: lessons from mouse models. Nat Rev Immunol. 2008; 8(10):802-15. DOI: 10.1038/nri2415. View

18.

Pfeffer M, Braunwald E, Moye L, Basta L, Brown Jr E, Cuddy T . Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators. N Engl J Med. 1992; 327(10):669-77. DOI: 10.1056/NEJM199209033271001. View

19.

Boring L, Gosling J, Cleary M, Charo I . Decreased lesion formation in CCR2-/- mice reveals a role for chemokines in the initiation of atherosclerosis. Nature. 1998; 394(6696):894-7. DOI: 10.1038/29788. View

20.

Naghavi M, Libby P, Falk E, Casscells S, Litovsky S, Rumberger J . From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part I. Circulation. 2003; 108(14):1664-72. DOI: 10.1161/01.CIR.0000087480.94275.97. View